LX102 Gene Therapy

· Innostellar Biotherapeutics Co.,Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LX102 Gene Therapy, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR) [Phase 3]

See pricing